Structural optimization and vibrational analysis of an antidiabetic drug tolbutamide
Yazarlar (5)
Yusuf Sert Yozgat Bozok University, Türkiye
Prof. Dr. Mustafa KARAKAYA Sinop Üniversitesi, Türkiye
Cąʇr Çrak Erzincan Binali Yıldırım Üniversitesi, Türkiye
Buse Eskiyurt
Erzincan Binali Yıldırım Üniversitesi, Türkiye
Mehmet Kürekçi
Erzincan Binali Yıldırım Üniversitesi, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Sulfur Chemistry (Q3)
Dergi ISSN 1741-5993 Dergi Bilgileri (2015)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 06-2015
Kabul Tarihi Yayınlanma Tarihi 04-06-2015
Cilt / Sayı / Sayfa 36 / 4 / 450–461 DOI 10.1080/17415993.2015.1050397
Makale Linki http://www.tandfonline.com/doi/full/10.1080/17415993.2015.1050397
UAK Araştırma Alanları
Atom, Molekül ve Lazer Fiziği
Özet
The purpose of this study is to investigate the vibrational spectrum of tolbutamide by ab initio techniques in combination with experimental studies. The Fourier transform infrared spectra (400–4000 cm−1) and Laser-Raman spectra (100–4000 cm−1) of tolbutamide have been obtained in the solid phase. Assignments have been found by the combination of the vibrational frequencies and the contribution of the potential energy distributions. Assignments have been compared with the theoretical and experimental results of similar structures as reported in the literature. Structural parameters such as bond lengths and angles, frequencies and infrared intensities and Raman activities of tolbutamide have been computed by density functional theory and Hartree–Fock methods using 6–311G++(d,p) and 6–31G(d) basis sets. The computed vibrational frequencies and optimized structural parameters are consistent with …
Anahtar Kelimeler
density functional theory | Fourier transform infrared spectra | Hartree-Fock method | Raman spectra | Tolbutamide
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Web of Science 8
Scopus 8
Google Scholar 9
Structural optimization and vibrational analysis of an antidiabetic drug tolbutamide

Paylaş